CODX - Co-DiagnosticsAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $10.16 | Open | $10.40 |
| Volume | 2.09M | Market Cap | 287.22M |
| Yield | Last Dividend |
| Co-Diagnostics to Present at H.C. Wainwr... | 01/07/21 |
| SALT LAKE CITY , Jan. 7, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX ) (the "Company"), a molecular diagnostics company with a unique, pat... | |
| Co-Diagnostics Anticipates Reporting Hig... | 01/06/21 |
| SALT LAKE CITY, Jan. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, pa... | |
| Concerns linger after Iowa spends $230K ... | 01/04/21 |
| Iowa has paid more than $230,000 so far to a Utah company for contact tracing software that still is causing delays for some public health departments... | |
| Co-Diagnostics, Inc. (NASDAQ:CODX) Direc... | 12/15/20 |
| Co-Diagnostics, Inc. (NASDAQ:CODX) Director Eugene Durenard sold 10,000 shares of the firm???s stock in a transaction that occurred on Thursday, Decem... | |
| Co-Diagnostics soars 15% after JV CoSara... | 11/25/20 |
| Co-Diagnostics (CODX +15.5%) announces that CoSara Diagnostics, its joint venture for manufacturing and sales in India, has received clearance by the ... | |
| Co-Diagnostics JV CoSara Receives Cleara... | 11/25/20 |
| SALT LAKE CITY, Nov. 25, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, pate... | |
| Co-Diagnostics, Inc. Receives CE Marking... | 11/17/20 |
| SALT LAKE CITY, Nov. 17, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform fo... | |
| Co-Diagnostics, Inc. CoPrimers??? Shown ... | 11/11/20 |
| SALT LAKE CITY, Nov. 11, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform fo... | |
| Co-Diagnostics, Inc. Announces Q3 2020 E... | 11/10/20 |
| SALT LAKE CITY , Nov. 10, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX ), a molecular diagnostics company with a unique, patented platform ... | |
| COVID-19 Detection Kits Market - Co-Diag... | 11/06/20 |
| The COVID-19 Detection Kits research report covers the current scenario and the growth prospects of the global COVID-19 Detection Kits industry foreca... | |
| Co-Diagnostics (NASDAQ:CODX) Trading Dow... | 10/23/20 |
| Co-Diagnostics, Inc. (NASDAQ:CODX) dropped 5.2% during trading on Wednesday . The stock traded as low as $12.53 and last traded at $12.61. Approximate... | |
| Co-Diagnostics (NASDAQ:CODX) Stock Price... | 10/21/20 |
| Co-Diagnostics, Inc. (NASDAQ:CODX)???s stock price dropped 5.2% during mid-day trading on Wednesday . The company traded as low as $12.53 and last tra... | |
| Co-Diagnostics, Inc. (NASDAQ:CODX) Sees ... | 10/21/20 |
| Co-Diagnostics, Inc. (NASDAQ:CODX) was the target of a large drop in short interest during the month of September. As of September 30th, there was sho... | |
| Co-Diagnostics, Inc. (NASDAQ:CODX) Short... | 10/20/20 |
| Co-Diagnostics, Inc. (NASDAQ:CODX) was the recipient of a large decrease in short interest in September. As of September 30th, there was short interes... | |
| ABMC to Distribute Co-Diagnostics Inc. E... | 10/07/20 |
| KINDERHOOK, NY / ACCESSWIRE / October 7, 2020 / American Bio Medica Corporation (OTC PINK:ABMC) today announced they have signed a distribution agreem... | |
| Co-Diagnostics, Inc. Logix Smart Kit to ... | 10/02/20 |
| SALT LAKE CITY , Oct. 2, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX ), a molecular diagnostics company with a unique, patented platform f... | |
| Co-Diagnostics introduces test that chec... | 09/28/20 |
| Co-Diagnostics CEO Dwight Egan joins Yahoo Finance???s Zack Guzman to discuss the company???s new ???ABC??? test, which checks patients for Influenza ... | |
| Co-Diagnostics, Inc. Provides Update on ... | 09/24/20 |
| SALT LAKE CITY, Sept. 24, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform f... | |
| Thinking about buying stock in Cassava S... | 09/14/20 |
| NEW YORK, Sept. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SAVA, MRSN, SRNE, DVAX, and CODX. To see how Investor... | |
| PolarityTE Announces Strategic Partnersh... | 09/08/20 |
| SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, tod... | |
| Co-Diagnostics??? Covid-19 Test Scores A... | 08/05/20 |
| Co-Diagnostics??? (CODX) Covid-19 detector, the Logix Smart COVID-19 Test kit, has scored the green light from The Australian Therapeutic Goods Admini... | |
| Deadline Reminder: The Law Offices of Ho... | 06/26/20 |
| Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Co-Diagnostics, Inc. | |
| CODX INVESTOR ALERT: Kirby McInerney LLP... | 06/22/20 |
| NEW YORK--(BUSINESS WIRE)---- $CODX #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.... | |
| Glancy Prongay & Murray LLP Announces th... | 06/19/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $CODX #classaction--Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Co-Dia... | |
| The Law Offices of Frank R. Cruz Announc... | 06/19/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $CODX #classaction--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf o... | |
| Law Offices of Howard G. Smith Announces... | 06/19/20 |
| Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Co-Diagnostics, Inc. securiti... | |
| The Law Offices of Frank R. Cruz Announc... | 06/18/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $CODX #classaction--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf o... | |
| Shareholder Alert: Robbins LLP Announces... | 06/18/20 |
| SAN DIEGO & SALT LAKE CITY--(BUSINESS WIRE)---- $CODX #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Co-Diagnosti... | |
| Glancy Prongay & Murray LLP, a National ... | 06/18/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $CODX #fraud--Glancy Prongay & Murray LLP, a National Class Action Law Firm, Announces Investigation of Co-Diagnostic... | |
| Has CoDiagnostics (CODX) Outpaced Other ... | 06/08/20 |
| Is (CODX) Outperforming Other Medical Stocks This Year? | |
| Buy rating | 12/15/20 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $29.00 to $30.00 | |
| Buy rating | 11/17/20 |
| HC Wainwright & Co. maintains Buy rating and lowers Price Target from $33.00 to $29.00 | |
| Date | 2020-11-16 (AMC) | Est. (EPS/Rev.) | $0.63/ 32.79M |
| Actual (EPS/Rev.) | $0.53/ $21.82 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Short & Long | Short & Long | 88.00 % | Subscribe |
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Tech Trades | Tech Trades | 81.00 % | Follow |
| Option short-term trading [Unusual] | Debashis K | 66.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
